Comments
Gilead bags blood disorder drug with YM BioSciences buy
13.12.2012. | (Reuters) - Gilead Sciences Inc said it would buy Canada's YM BioSciences Inc for about $510 million in cash, getting access to a second experimental drug to treat a rare blood and immune cell disorder....
